Investors
Bioxodes is a Belgian private company, founded in 2010. The Company has received fundings from both public and private investors.
video testimonial
Watch our CEO Marc Dechamps present Bioxodes to investors in Zurich
with support from world-renowned stroke expert Prof Robin Lemmens, head of the stroke unit at the University Hospital Leuven (Belgium), and Hans Warrinnier, Bioxodes Chief Medical Officer.
Investors
Public & private investors
Private Equity
(Euros)
Grants/subsidies from the Walloon Region
(Euros)
Investors
Who invests?
Investors
Why invest?
-
First-in-class lead compound with solid preclinical and Phase I clinical data.
-
Discovery program for innovative pipeline to extend value capture beyond thrombo-inflammation.
-
Leadership and expertise with international advisor network.
-
Patent portfolio wholly owned with coverage beyond 2040.
Investors
Invest in us
Get in touch and explore our investment opportunities
investment@bioxodes.com